Low-Dose Bevacizumab in HCC: Unresolved Questions on Hepatic Reserve, Cost Claims, and LRT Heterogeneity.
OpenAlex 토픽 ·
Hepatocellular Carcinoma Treatment and Prognosis
Colorectal Cancer Treatments and Studies
Hepatitis B Virus Studies
APA
Jiajing Zhao, Liping Liu (2026). Low-Dose Bevacizumab in HCC: Unresolved Questions on Hepatic Reserve, Cost Claims, and LRT Heterogeneity.. Liver international : official journal of the International Association for the Study of the Liver, 46(5), e70651. https://doi.org/10.1111/liv.70651
MLA
Jiajing Zhao, et al.. "Low-Dose Bevacizumab in HCC: Unresolved Questions on Hepatic Reserve, Cost Claims, and LRT Heterogeneity.." Liver international : official journal of the International Association for the Study of the Liver, vol. 46, no. 5, 2026, pp. e70651.
PMID
42003603
같은 제1저자의 인용 많은 논문 (5)
- The Effect of CDT-Based Rehabilitation Nursing on Breast Cancer-related Lymphedema.
- Prognostic value of BMI, prognostic nutritional index, and CRP in patients with lymphoma after autologous hematopoietic stem cell transplantation.
- Analysis of independent prognostic factors for the occurrence and severity of heart failure after chemotherapy in patients with small cell lung cancer.
- Silymarin sensitizes human colorectal cancer cells to 5-ALA-mediated photodynamic therapy by enhancing cytotoxicity and apoptotic signaling in vitro.
- Exploratory Investigation Into Perioperative Treatment Strategies for Potentially Resectable Stage III-N2 Driver Gene-Negative Non-Small Cell Lung Cancer in the Immunotherapy Era.